RHB Research

SINGAPORE (Feb 22): Maybank Kim Eng, OCBC Investment Research, RHB Research and CGS-CIMB Research are maintaining their “buy” calls on Genting Singapore (GENS) with the respective target prices of $1.26, $1.31, $1.22 and $1.28.  

SINGAPORE (Feb 20): RHB Research is maintaining “neutral” on Kimly Limited with a lower target price of 24 cents after lowering FY19F PATMI by 5% and says it sees limited potential upside to the stock despite its reasonable valuations.

SINGAPORE (Feb 19): Jefferies Singapore, OCBC Investment Research and RHB Research are maintaining their “buy” calls on DBS Group while lowering their price targets to $28.50, $29.31 and $28.80, respectively.

SINGAPORE (Feb 18): RHB Research and UOB Kay Hian are maintaining their “neutral” and “sell” calls on StarHub with target prices of $2.02 and $1.45, respectively.

SINGAPORE (Feb 15): RHB Research and DBS Vickers Securities are maintaining their “buy” calls on Silverlake Axis with target prices of 65 cents and 62 cents, which represent a 26% and 19% upside, respectively.

SINGAPORE (Feb 12): RHB Research is maintaining its “buy” call on Manulife US REIT with a higher target price of 94 US cents compared to 92 US cents previously, upon lowering COE assumptions to 8.3% from 8.4% in its dividend discount model (DDM) to r

SINGAPORE (Feb 4): Dormitory operator Centurion Corp might have launched Penang’s first purpose-built workers accommodation (PBWA), but analysts say this will be unlikely to fill the void left by the group’s Westlite Tuas dormitory, which ceased opera

SINGAPORE (Jan 25): RHB Research is keeping its “buy” call on Singapore Exchange (SGX) with an unchanged target price of $8.20, on the back of strong growth in its derivatives business.

SINGAPORE (Jan 24): Analysts believe Suntec REIT could see better days ahead with retail continuing to improve and office rents expected to be on a multi-year upturn.